Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03709277 · ClinicalTrials.gov registry record · NA
Interventions to Improve Specialty Medication Adherence
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 438
- Enrollment target
NCT03709277 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 438 participants.
The verdict
NCT03709277, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 438 participants
- Enrollment target
Study Summary
Patients deemed nonadherent to their specialty medications will be randomized to receive 8 months of patient-tailored adherence interventions and follow up from a specialty pharmacist as needed or the standard of care. Medication adherence will be measured using proportion of days covered (PDC) at 8-months post-randomization to determine if the intervention improved specialty medication adherence.
Interventions
- BEHAVIORAL Pharmacist-Driven Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 438 participants |
| Start Date | 2019-05-10 |
| Est. Completion | 2022-04-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03709277
The ClinicalTrials.gov registry entry for NCT03709277 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 438 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pharmacist-Driven Intervention is the first listed.
NCT03709277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03709277 about?
NCT03709277 is a clinical study titled "Interventions to Improve Specialty Medication Adherence". Patients deemed nonadherent to their specialty medications will be randomized to receive 8 months of patient-tailored adherence interventions and follow up from a specialty pharmacist as needed or the standard of care. Medication adherence will be measured using proportion of days covered (PDC) at 8...
What is the current status of trial NCT03709277?
This trial is currently completed. It is a NA study. The enrollment target is 438 participants. The study started on 2019-05-10. Estimated completion is 2022-04-10.
What interventions are being tested in trial NCT03709277?
The interventions under investigation include: Pharmacist-Driven Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03709277?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.